QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
20 hedge funds and large institutions have $1.38M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.04% more ownership
Funds ownership: 0.01% → 0.05% (+0.04%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Holders
20
Holding in Top 10
–
Calls
$269K
Puts
$120K
Top Buyers
| 1 | +$1.31M | |
| 2 | +$83.8K | |
| 3 | +$36.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$22K |
| 5 |
Renaissance Technologies
New York
|
+$17.8K |
Top Sellers
| 1 | -$74.6K | |
| 2 | -$67K | |
| 3 | -$20.8K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$16K |
| 5 |
Morgan Stanley
New York
|
-$2K |